Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Fig. 1.02 Incidence of female <strong>breast</strong> cancer by age<br />
in selected populations 1988-1993. From M. Parkin<br />
et al. {2189}.<br />
data it has clearly emerged that <strong>breast</strong><br />
cancer is a disease of affluent societies<br />
which have acquired the We s t e rn<br />
lifestyle, characterized by a high-caloric<br />
diet rich in animal fat and proteins, combined<br />
with a lack of physical exercise.<br />
Regions which have featured this<br />
lifestyle for a long period of time (Nort h<br />
America, Nort h e rn Europe, Australia)<br />
have reached a plateau of an incidence<br />
rate of 70 to 90 new cases per 100,000<br />
population/year while countries that<br />
have more recently become industrialized<br />
and affluent show a marked<br />
i n c rease in incidence and mort a l i t y. In<br />
addition to <strong>breast</strong> cancer, the We s t e rn<br />
lifestyle carries a high risk of cancer<br />
of the prostate, colon/rectum, and<br />
endometrium. Specific enviro n m e n t a l<br />
e x p o s u res operative in the development<br />
of <strong>breast</strong> cancer (e.g. radiation, alcohol,<br />
exogenous hormones) have been identified<br />
but carry a lower risk.<br />
More than most other human neoplasms,<br />
<strong>breast</strong> cancer often shows familial clustering.<br />
Two high penetrance genes have<br />
been identified (BRCA1/2) which greatly<br />
i n c rease the <strong>breast</strong> cancer risk (see<br />
Chapter 8). However, it is anticipated that<br />
multigenic traits also play a significant<br />
role in the inherited susceptibility to<br />
<strong>breast</strong> cancer.<br />
Reproductive lifestyle<br />
For almost half a century, the events of<br />
re p roductive life have been considere d<br />
to be risk factors for <strong>breast</strong> cancer in<br />
women. Breast cancer occurs more frequently<br />
among women who have an<br />
early menarche, remain nulliparous or, if<br />
p a rous, have few children with a late age<br />
at first delivery. Infertility per se appears<br />
to be a risk factor as may be lack of<br />
b reast-feeding. Finally, late age at<br />
menopause also increases the risk<br />
{ 1 4 3 0 } .<br />
Most of these factors have also been<br />
found relevant in populations at low risk<br />
of <strong>breast</strong> cancer such as the Japanese<br />
and Chinese. Although the data is limited<br />
in Africa, at least one study confirmed<br />
the negative impact of late age at first<br />
delivery, reduced number of pregnancies<br />
and shorter <strong>breast</strong> feeding time<br />
{2770}. Recent data indicates that the<br />
age at any delivery, not just the first is<br />
associated with <strong>breast</strong> cancer risk, with<br />
deliveries occurring before the age of 30<br />
having a protective effect {3137}.<br />
Controversies still surround the issue of<br />
abortion, some studies, but not others,<br />
Fig. 1.04 Female <strong>breast</strong> cancer mortality trends.<br />
Source: WHO/NCHS.<br />
finding an increased risk for induced<br />
abortion. Similarly, the protective effect of<br />
lactation, once considered quite a strong<br />
factor, was later given less importance;<br />
its impact appears limited to long-term<br />
cumulative <strong>breast</strong> feeding, pre f e r a b l y<br />
exceeding two years {435}.<br />
Exogenous hormones<br />
Two major types of hormonal compounds<br />
have been evaluated in re l a t i o n<br />
to <strong>breast</strong> cancer: oral contraceptives<br />
and menopausal replacement therapy.<br />
The evidence suggests a small increase<br />
in the relative risk associated with the use<br />
of combined oral contraceptives, especially<br />
among current and recent users,<br />
which is not related to duration of use<br />
and type or dose of preparation, and<br />
may be partly linked to detection bias<br />
{1296}. Data on injectable pure progestogen<br />
contraceptives shows relative risks<br />
from 1.0 to 1.3, which are not statistically<br />
significant {1294}.<br />
Epidemiological studies on postmenop<br />
a u s a l e s t rogen therapy show a small<br />
i n c rease in risk with longer duration of use<br />
in current and recent users {1298}.<br />
I n f o rmation on the effect of postmenopausal<br />
estro g e n - p rogestogen therapy<br />
was provided in only a minority of studies,<br />
but indicates that the increased re l a t i v e<br />
risk in long-term users is not significantly<br />
d i ff e rent from that for long-term use of<br />
e s t rogens alone {1297}. Yet it should be<br />
noted that, among hormone re p l a c e m e n t<br />
therapy users, there is an over re p re s e n t a-<br />
tion of tumours that, with re g a rd to tumour<br />
stage, type and grade are associated with<br />
a more favourable prognosis {1760}.<br />
Fig. 1.03 Aetiological factors involved in the development of <strong>breast</strong> cancer.<br />
Nutrition<br />
High intakes of fruit and vegetables are<br />
p robably associated with a slightly<br />
reduced risk of <strong>breast</strong> cancer {3153}.<br />
14 Tumours of the <strong>breast</strong>